Akorn Recalls Halyard Chlorhexidine Oral Rinse Due to Crystallization
Akorn Inc is recalling Halyard 24-Hour Oral Care Kits containing chlorhexidine gluconate oral rinse due to crystallization and subpotent assay results.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which indicates a violation of labeling or FDA regulations that is not likely to cause adverse health consequences. The hazard is subpotency (reduced effectiveness) rather than toxicity or injury.
Plain-English summary
Akorn Inc is voluntarily recalling Halyard 24-Hour Oral Care Kit q2, which contains 2x15 mL Unit Dose Cups of 0.12% Chlorhexidine Gluconate Oral Rinse. The recall involves 40,978 unit dose cups distributed nationwide in the USA. The product was manufactured by Halyard Health Inc. and distributed by Halyard Sales, LLC.
The recall was initiated because of crystallization and subpotent out-of-specification assay results for chlorhexidine. This means the active ingredient in the affected units may not be at the intended strength, potentially reducing the product's effectiveness.
Consumers and healthcare facilities should stop using the affected product and contact Akorn Inc for further instructions. The affected lots are identified by specific lot numbers and expiration dates of 06-2018 and 07-2018 as listed in the recall notice.
The recalled product
- Product
- Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse. Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97012
- Manufacturer
- Akorn Inc
- Category
- Drug — Oral Rinse
- Affected units
- 40,978
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lots: 0202623109
- 0202623110
- 0202623111
- 0202630207
- 0202630208
- 0202630209
- EXP 06-2018
- 0202642227
- 0202642228
- 0202647413
- 0202647414
- 0202653433
- 0202653434
- EXP 07-2018.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Akorn Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Akorn Inc
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22